Utilization of triacylglycerol-rich lipoproteins by the working rat heart: Routes of uptake and metabolic fates

Journal of Physiology

Volumn 558, Issue 1, 2004, Pages 225-237

  Niu, You Guo ^a,b   Hauton, David ^a   Evans, Rhys D ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHYLOMICRON; FATTY ACID; LIPOPROTEIN; LIPOPROTEIN LIPASE; LIPOPROTEIN RECEPTOR; SURAMIN; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; CARBON 14; CHOLESTEROL; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ESTERIFICATION; HEART FUNCTION; HEART MUSCLE CELL; HYDROLYSIS; ISOLATED HEART; LIPID METABOLISM; MALE; METABOLIC REGULATION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN TRANSPORT; RAT; TARGET CELL; HEART WORK; LIPID OXIDATION; LIPID TRANSPORT; LIPOPROTEIN METABOLISM; PROTEIN HYDROLYSIS;

ANIMALS; BINDING SITES; CARBON RADIOISOTOPES; CHOLESTEROL, VLDL; ENERGY METABOLISM; ENZYME INHIBITORS; LACTONES; LIPOPROTEIN LIPASE; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; RATS; RATS, WISTAR; TRIGLYCERIDES; TRITIUM;

EID: 4043063526     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2004.061473     Document Type: Article

References (55)

1. Abumrad N, Harmon C & Ibrahimi A (1998). Membrane transport of long-chain fatty acids: evidence for a facilitated process, J Lipid Res 39, 2309-2318.
2. Augustus AS, Kako Y, Yagyu H & Goldberg IJ (2003). Routes of FA delivery to cardiac muscle: modulation of lipoprotein lipolysis alters uptake of TG-derived FA. Am J Physiol Endocrinol Metab 284, E331-E339.
3. Auwerx J, Leroy P & Schoonjans K (1992). Lipoprotein lipase: recent contributions from molecular biology. Crit Rev Clin Laboratory Sci 29, 243-268.
4. Beisiegel U, Weber W & Bengtsson Olivecrona G (1991). Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc Natl Acad Sci U S A 88, 8342-8346.
5. Belke DD, Larsen TS, Lopaschuk GD & Severson DL (1999). Glucose and fatty acid metabolism in the isolated working mouse heart. Am J Physiol 277, R1210-R1217.
6. Bennett MJ, Hauton D, Hole DG & Evans RD (2000a). Preparation of radiolabelled very-low-density lipoprotein (VLDL) in high yield by extended rat liver perfusion. Biotechnol Lett 22, 301-306.
7. Bennett MJ, Hauton D, Hole DG & Evans RD (2000b). Utilization of very low density lipoprotein by rat heart: the effect of endotoxin. Am J Physiol Endocrinol Metab 278, E802-E810.
8. Bezman-Tarcher A, Otway S & Robinson DS (1965). The removal of triglyceride fatty acids from the incubation of the supradiaphragmatic portion of the rat. Proc Roy Soc B 162, 411-426.
9. Bhattacharya S & Redgrave TG (1981). The content of apolipoprotein B in chylomicron particles. J Lipid Res 22, 820-828.
10. Boren J, Veniant MM & Young SG (1998). Apo B100-containing lipoproteins are secreted by the heart. J Clin Invest 101, 1197-1202.
11. Braun JE & Severson DL (1992). Regulation of the synthesis, processing and translocation of lipoprotein lipase. Biochem J 287, 337-347.
12. Brown ML, Ramprasad MP, Umeda PK, Tanaka A, Kobayashi Y, Watanabe T, Shimoyamada H, Kuo WL, Li R, Song R, Bradley WA & Gianturco SH (2000). A macrophage receptor for apolipoprotein B48: cloning, expression, and atherosclerosis. Proc Natl Acad Sci U S A 97, 7488-7493.
13. Brown SA, Via DP, Gotto AM Jr, Bradley WA & Gianturco SH (1986). Apolipoprotein E-mediated binding of hypertriglyceridemic very low density lipoproteins to isolated low density lipoprotein receptors detected by ligand blotting. Biochem Biophys Res Commun 139, 333-340.
14. Calvani M, Reda E & Arrigoni Martelli E (2000). Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions. Basic Res Cardiol 95, 75-83.
15. Chawla A, Barak Y, Nagy L, Liao D, Tontonoz P & Evans RM (2001). PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med 7, 48-52.
16. Eckel RH (1989). Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N Engl J Med 320, 1060-1068.
17. Elovson J, Chatterton JE, Bell GT, Schumaker VN, Reuben MA, Puppione DL, Reeve JR Jr & Young NL (1988). Plasma very low density lipoproteins contain a single molecule of apolipoprotein B. J Lipid Res 29, 1461-1473.
18. Enerback S & Gimble JM (1993). Lipoprotein lipase gene expression: physiological regulators at the transcriptional and post-transcriptional level. Biochim Biophys Acta 1169, 107-125.
19. Evans RD & Wang X (1997). Measurement of fatty acid oxidation in isolated perfused rat heart. A simple and accurate method. Biotechnol Techniques 11, 127-132.
20. Gianturco SH, Ramprasad MP, Song R, Li R, Brown ML & Bradley WA (1998). Apolipoprotein B-48 or its apolipoprotein B-100 equivalent mediates the binding of triglyceride-rich lipoproteins to their unique human monocyte-macrophage receptor. Arterioscler Thromb Vasc Biol 18, 968-976.
21. Goldberg IJ (1996). Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 37, 693-707.
22. Hauton D, Bennett MJ & Evans RD (2001). Utilisation of triacylglycerol and non-esterified fatty acid by the working rat heart: myocardial lipid substrate preference. Biochim Biophys Acta 1533, 99-109.
23. Huettinger M, Retzek H, Hermann M & Goldenberg H (1992). Lactoferrin specifically inhibits endocytosis of chylomicron remnants but not alpha-macroglobulin. J Biol Chem 267, 18551-18557.
24. Hultin M, Carneheim C, Rosenqvist K & Olivecrona T (1995). Intravenous lipid emulsions: removal mechanisms as compared to chylomicrons. J Lipid Res 36, 2174-2184.
25. Imaizumi K, Fainaru M & Havel RJ (1978). Composition of proteins of mesenteric lymph chylomicrons in the rat and alterations produced upon exposure of chylomicrons to blood serum and serum proteins. J Lipid Res 19, 712-722.
26. Kamataki A, Takahashi S, Masamura K, Iwasaki T, Hattori H, Naiki H, Yamada K, Suzuki J, Miyamori I, Sakai J, Fujino T & Yamamoto TT (2002). Remnant lipoprotein particles are taken up into myocardium through VLDL receptor - a possible mechanism for cardiac fatty acid metabolism. Biochem Biophys Res Commun 293, 1007-1013.
27. Karpe F & Hultin M (1995). Endogenous triglyceride-rich lipoproteins accumulate in rat plasma when competing with a chylomicron-like triglyceride emulsion for a common lipolytic pathway. J Lipid Res 36, 1557-1566.
28. Krebs M, Stingl H, Nowotny P, Weghuber D, Bischof M, Waldhausl W & Roden M (2000). Prevention of in vitro lipolysis by tetrahydrolipstatin. Clin Chem 46, 950-954.
29. Levak Frank S, Hofmann W, Weinstock PH, Radner H, Sattler W, Breslow JL & Zechner R (1999). Induced mutant mouse lines that express lipoprotein lipase in cardiac muscle, but not in skeletal muscle and adipose tissue, have normal plasma triglyceride and high-density lipoprotein-cholesterol levels. Proc Natl Acad Sci U S A 96, 3165-3170.
30. Lookene A, Skottova N & Olivecrona G (1994). Interactions of lipoprotein lipase with the active-site inhibitor tetrahydrolipstatin (Orlistat). Eur J Biochem 222, 395-403.
31. Lopaschuk GD (1997). Alterations in fatty acid oxidation during reperfusion of the heart after myocardial ischemia. Am J Cardiol 80, 11a-16a.
32. Lopaschuk GD, Belke DD, Gamble J, Itoi T & Schonekess BO (1994). Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1213, 263-276.
33. Luiken JJ, Schaap FG, van Nieuwenhoven FA, van der Vusse GJ, Bonen A & Glatz JF (1999). Cellular fatty acid transport in heart and skeletal muscle as facilitated by proteins. Lipids 34, S169-S175.
34. Mardy K, Belke DD & Severson DL (2001). Chylomicron metabolism by the isolated perfused mouse heart. Am J Physiol Endocrinol Metab 281, E357-E364.
35. Martins IJ, Hone E, Chi C, Seydel U, Martins RN & Redgrave TG (2000). Relative roles of LDLr and LRP in the metabolism of chylomicron remnants in genetically manipulated mice. J Lipid Res 41, 205-213.
36. Masuzaki H, Jingami H, Matsuoka N, Nakagawa O, Ogawa Y, Mizuno M, Yoshimasa Y, Yamamoto T & Nakao K (1996). Regulation of very-low-density lipoprotein receptor in hypertrophic rat heart. Circ Res 78, 8-14.
37. Merkel M, Eckel RH & Goldberg IJ (2002). Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res 43, 1997-2006.
38. Milosavljevic D, Kontush A, Griglio S, Le Naour G, Thillet J & Chapman MJ (2003). VLDL-induced triglyceride accumulation in human macrophages is mediated by modulation of LPL lipolytic activity in the absence of change in LPL mass. Biochim Biophys Acta 1631, 51-60.
39. Nilsson Ehle P & Schotz MC (1976). A stable, radioactive substrate emulsion for assay of lipoprotein lipase. J Lipid Res 17, 536-541.
40. Potts JL, Coppack SW, Fisher RM, Humphreys SM, Gibbons GF & Frayn KN (1995). Impaired postprandial clearance of triacylglycerol-rich lipoproteins in adipose tissue in obese subjects. Am J Physiol 268, E588-E594.
41. Saddik M & Lopaschuk GD (1991). Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J Biol Chem 266, 8162-8170.
42. Sakai J, Hoshino A, Takahashi S, Miura Y, Ishii H, Suzuki H, Kawarabayasi Y & Yamamoto T (1994). Structure, chromosome location, and expression of the human very low density lipoprotein receptor gene. J Biol Chem 269, 2173-2182.
43. Sambandam N, Abrahani MA, Craig S, Al Atar O, Jeon E & Rodrigues B (2000). Metabolism of VLDL is increased in streptozotocin-induced diabetic rat hearts. Am J Physiol Heart Circ Physiol 278, H1874-H1882.
44. Schaap FG, van der Vusse GJ & Glatz JF (1998). Fatty acid-binding proteins in the heart. Mol Cell Biochem 180, 43-51.
45. Strauss JG, Zimmermann R, Hrzenjak A, Zhou Y, Kratky D, Levak Frank S, Kostner GM, Zechner R & Frank S (2002). Endothelial cell-derived lipase mediates uptake and binding of high-density lipoprotein (HDL) particles and the selective uptake of HDL-associated cholesterol esters independent of its enzymic activity. Biochem J 368, 69-79.
46. Taegtmeyer H, Hems R & Krebs HA (1980). Utilization of energy-providing substrates in the isolated working rat heart. Biochem J 186, 701-711.
47. Takahashi S, Suzuki J, Kohno M, Oida K, Tamai T, Miyabo S, Yamamoto T & Nakai T (1995). Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase. J Biol Chem 270, 15747-15754.
48. Tam SP & Breckenridge WC (1983). Apolipoprotein and lipid distribution between vesicles and HDL-like particles formed during lipolysis of human very low density lipoproteins by perfused rat heart. J Lipid Res 24, 1343-1357.
49. Tiebel O, Oka K, Robinson K, Sullivan M, Martinez J, Nakamuta M, Ishimura Oka K & Chan L (1999). Mouse very low-density lipoprotein receptor (VLDLR): gene structure, tissue-specific expression and dietary and developmental regulation. Atherosclerosis 145, 239-251.
50. van der Vusse GJ, van Bilsen M & Glatz JF (2000). Cardiac fatty acid uptake and transport in health and disease. Cardiovasc Res 45, 279-293.
51. Wang X, Hole DG, Da Costa TH & Evans RD (1998). Alterations in myocardial lipid metabolism during lactation in the rat. Am J Physiol 275, E265-E271.
52. Xiang SQ, Cianflone K, Kalant D & Sniderman AD (1999). Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase. J Lipid Res 40, 1655-1663.
53. Yagyu H, Chen G, Yokoyama M, Hirata K, Augustus A, Kako Y, Seo T, Hu Y, Lutz EP, Merkel M, Bensadoun A, Homma S & Goldberg IJ (2003). Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy. J Clin Invest 111, 419-426.
54. Yagyu H, Lutz EP, Kako Y, Marks S, Hu Y, Choi SY, Bensadoun A & Goldberg IJ (2002). Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency. J Biol Chem 277, 10037-10043.
55. Zakim D (1996). Fatty acids enter cells by simple diffusion. Proc Soc Exp Biol Medical 212, 5-14.